Wikidata

(Q73421046)

English

Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)

scientific article published on 01 January 2000

In more languages

Statements

title
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10663618
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10663618%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q73421046&oldid=1758888372"